Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 30;22(4):697-698.
doi: 10.9758/cpn.24.1209. Epub 2024 Aug 23.

Enhancing the Understanding of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies in Chronic Migraine Prevention

Prashant Soni  1
Affiliations

Enhancing the Understanding of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies in Chronic Migraine Prevention

Prashant Soni. Clin Psychopharmacol Neurosci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

References

    1. Haridas MP, Tripathy A, Maiti R, Srinivasan A. Efficacy and safety of anti-CGRP monoclonal antibodies in prevention of chronic migraine: a Bayesian network meta-analysis. Clin Psychopharmacol Neurosci. 2024;22:23–32. doi: 10.9758/cpn.23.1109. - DOI - PMC - PubMed
    1. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–784. doi: 10.7326/M14-2385. - DOI - PubMed
    1. Puhan MA, Schünemann HJ, Murad MH, Li T, Brignardello-Petersen R, Singh JA, et al. ; GRADE Working Group. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630. doi: 10.1136/bmj.g5630. - DOI - PubMed
    1. Naghdi S, Underwood M, Madan J, Brown A, Duncan C, Matharu M, et al. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis. J Headache Pain. 2023;24:164. doi: 10.1186/s10194-023-01696-w. - DOI - PMC - PubMed
    1. Dodick DW, Lipton RB, Silberstein S, Goadsby PJ, Biondi D, Hirman J, et al. Eptinezumab for prevention of chronic migraine: a randomized phase 2b clinical trial. Cephalalgia. 2019;39:1075–1085. doi: 10.1177/0333102419858355. - DOI - PubMed